{"transactions":[{"id":755127,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42447,"kind":"person","name":"Gryaznov Sergei","position":1,"cik":"0001913228","reported_name":"Gryaznov Sergei","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-06-02T13:00:31.000Z","date":"2026-06-01","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":1.345,"value":2690.0,"ownership":{"direct":true},"balance_after":46511,"source":{"system":"sec-edgar","filing":"0001878313-26-000060","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000060/form4.xml","form_type":"4"}},{"id":757258,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42447,"kind":"person","name":"Gryaznov Sergei","position":1,"cik":"0001913228","reported_name":"Gryaznov Sergei","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options","published_at":"2026-06-01T12:51:53.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on May 29, 2026 pursuant to MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary date of the grant and the remaining options to vest ratably monthly thereafter for 36 months."}],"balance_after":400000,"derivative":{"exercise_price":1.39,"expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001878313-26-000051","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000051/form4.xml","form_type":"4"}},{"id":808890,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42447,"kind":"person","name":"Gryaznov Sergei","position":1,"cik":"0001913228","reported_name":"Gryaznov Sergei","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options","published_at":"2026-04-14T12:44:12.000Z","date":"2026-04-10","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on April 10, 2026 pursuant to MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary date of the grant and the remaining options to vest ratably monthly thereafter for 36 months."}],"balance_after":400000,"derivative":{"exercise_price":1.28,"exercise_date":"2027-04-10","expiration_date":"2036-04-10","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001878313-26-000046","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000187831326000046/form4.xml","form_type":"4"}},{"id":1145656,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42447,"kind":"person","name":"Gryaznov Sergei","position":1,"cik":"0001913228","reported_name":"Gryaznov Sergei","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options","published_at":"2025-05-16T20:14:36.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on May 14, 2025 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary of the date of the grant and the remaining options to vest ratably monthly thereafter for 36 months."}],"balance_after":200000,"derivative":{"exercise_price":1.76,"expiration_date":"2035-05-14","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001127602-25-014669","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225014669/form4.xml","form_type":"4"}},{"id":1271933,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42447,"kind":"person","name":"Gryaznov Sergei","position":1,"cik":"0001913228","reported_name":"Gryaznov Sergei","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options","published_at":"2025-02-12T21:11:42.000Z","date":"2025-02-10","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on February 10, 2025 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary of the date of the grant and the remaining options to vest ratably monthly thereafter for 36 months."}],"balance_after":200000,"derivative":{"exercise_price":1.81,"expiration_date":"2035-02-10","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001127602-25-004350","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760225004350/form4.xml","form_type":"4"}},{"id":1532939,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42447,"kind":"person","name":"Gryaznov Sergei","position":1,"cik":"0001913228","reported_name":"Gryaznov Sergei","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options","published_at":"2024-04-30T21:05:48.000Z","date":"2024-04-26","kind":"grant","planned":false,"acquired":true,"shares":141000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on April 26, 2024 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversay of the date of the grant and the remaining options to vest ratably monthly thereafter for 36 months."}],"balance_after":141000,"derivative":{"exercise_price":2.94,"expiration_date":"2034-04-26","underlying":"Common Stock","underlying_shares":141000},"source":{"system":"sec-edgar","filing":"0001127602-24-013658","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224013658/form4.xml","form_type":"4"}},{"id":1669780,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42447,"kind":"person","name":"Gryaznov Sergei","position":1,"cik":"0001913228","reported_name":"Gryaznov Sergei","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options","published_at":"2024-01-26T21:10:34.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on January 24, 2024 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary of the date of the grant and the remaining options to vest ratably monthly thereafter for 36 months."}],"balance_after":100000,"derivative":{"exercise_price":1.41,"expiration_date":"2034-01-24","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001127602-24-002276","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760224002276/form4.xml","form_type":"4"}},{"id":1867467,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42447,"kind":"person","name":"Gryaznov Sergei","position":1,"cik":"0001913228","reported_name":"Gryaznov Sergei","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options","published_at":"2023-06-05T21:17:33.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":75982,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on May 31, 2023 pursuant to MAIA Biotechnology, Inc's 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest 100% on the date of the grant and are exercisable beginning as of that date."}],"balance_after":75982,"derivative":{"exercise_price":2.5,"exercise_date":"2023-05-31","expiration_date":"2032-05-30","underlying":"Common Stock","underlying_shares":75982},"source":{"system":"sec-edgar","filing":"0001127602-23-017879","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223017879/form4.xml","form_type":"4"}},{"id":1959065,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42447,"kind":"person","name":"Gryaznov Sergei","position":1,"cik":"0001913228","reported_name":"Gryaznov Sergei","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options","published_at":"2023-03-10T22:12:00.000Z","date":"2023-03-08","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on March 8, 2023 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary of the date of grant and the remaining options to vest ratably monthly thereafter for 36 months."}],"balance_after":100000,"derivative":{"exercise_price":4.1,"expiration_date":"2033-03-08","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001127602-23-009775","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760223009775/form4.xml","form_type":"4"}},{"id":2092355,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42447,"kind":"person","name":"Gryaznov Sergei","position":1,"cik":"0001913228","reported_name":"Gryaznov Sergei","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options","published_at":"2022-12-08T22:36:45.000Z","date":"2022-12-07","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an option to purchase shares of Common Stock granted pursuant to the 2020 Equity Incentive Plan. These options vest in 36 equal monthly instalments beginning on January 1, 2021."}],"balance_after":40000,"derivative":{"exercise_price":1.83,"expiration_date":"2031-04-15","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001127602-22-027093","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760222027093/form4.xml","form_type":"4"}},{"id":2092354,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42447,"kind":"person","name":"Gryaznov Sergei","position":1,"cik":"0001913228","reported_name":"Gryaznov Sergei","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-12-08T22:36:45.000Z","date":"2022-12-07","kind":"exercise","acquired":true,"shares":10000,"price":1.83,"value":18300.0,"ownership":{"direct":true},"balance_after":44511,"source":{"system":"sec-edgar","filing":"0001127602-22-027093","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760222027093/form4.xml","form_type":"4"}},{"id":2154198,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42447,"kind":"person","name":"Gryaznov Sergei","position":1,"cik":"0001913228","reported_name":"Gryaznov Sergei","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options","published_at":"2022-09-20T15:21:13.000Z","date":"2022-09-16","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options, granted on September 16, 2022 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary of the date of grant and the remaining options to vest ratably monthly thereafter for 36 months."}],"balance_after":100000,"derivative":{"exercise_price":3.56,"expiration_date":"2032-09-16","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001127602-22-022740","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000112760222022740/form4.xml","form_type":"4"}},{"id":2174033,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42447,"kind":"person","name":"Gryaznov Sergei","position":1,"cik":"0001913228","reported_name":"Gryaznov Sergei","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options","published_at":"2022-08-25T20:47:03.000Z","date":"2022-08-24","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the right to buy shares of Common Stock granted pursuant to the 2018 Stock Option Plan. These options vested in four equal monthly installments beginning on December 1, 2019."}],"balance_after":48000,"derivative":{"exercise_price":1.8,"expiration_date":"2029-11-30","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-22-029752","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000089924322029752/doc4.xml","form_type":"4"}},{"id":2174032,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42447,"kind":"person","name":"Gryaznov Sergei","position":1,"cik":"0001913228","reported_name":"Gryaznov Sergei","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-08-25T20:47:03.000Z","date":"2022-08-24","kind":"exercise","acquired":true,"shares":10000,"price":1.8,"value":18000.0,"ownership":{"direct":true},"balance_after":34511,"source":{"system":"sec-edgar","filing":"0000899243-22-029752","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000089924322029752/doc4.xml","form_type":"4"}},{"id":2197920,"issuer":{"id":6919,"kind":"organization","name":"MAIA Biotechnology, Inc.","symbol":"MAIA"},"owners":[{"id":42447,"kind":"person","name":"Gryaznov Sergei","position":1,"cik":"0001913228","reported_name":"Gryaznov Sergei","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-08-02T22:33:03.000Z","date":"2022-08-01","kind":"purchase","acquired":true,"shares":3000,"price":5,"value":15000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were purchased by the reporting person in the issuer's initial public offering, which closed on August 1, 2022."}],"balance_after":24511,"source":{"system":"sec-edgar","filing":"0000899243-22-027455","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1878313/000089924322027455/doc4.xml","form_type":"4"}}]}